Navigation Links
In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Nearly Half Will Use CDA1/CDB1
Date:8/5/2010

eutic Area Director Danielle Drayton, Ph.D. "Over the past 12 months, 82 percent of surveyed infectious disease specialists observed an increase in the incidence of ESBL-producing enterobacteriaceae while more than half of surveyed clinicians also point to an increase in the incidence of CDI and MRSA. Drugs that target key gram-negative pathogens such as Pseudomonas aeruginosa and ESBL-producing enterobacteriaceae and Clostridium difficile stand to address a key unmet need and will capitalize on untapped market opportunities."

The report also finds that Forest/AstraZeneca/Takeda's ceftaroline and Trius's torezolid are the two late-stage emerging therapies that are most likely to gain formulary inclusion, according to surveyed P&T committee members. Seventy one percent of surveyed P&T committee members expect torezolid to be on formulary and 62 percent expect ceftaroline to be on formulary.

Hospital Anti-Infectives: Insights on the Uptake and Formulary Inclusion of Emerging Antibiotics and Antifungals—A Survey of Infectious Disease Specialists, Internists and P&T Committee Members is based on a U.S. survey of 51 infectious disease specialists, 52 internal medicine specialists and 21 infectious disease specialists who sit on their hospital's P&T committee.

About Decision Resources

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision R
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
2. WuXi PharmaTech Announces First-Quarter 2010 Results
3. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
4. Ligon Discovery and Lycera Collaborate to Develop First-in-Class Drugs for Immune Disorders
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. VELOCITY Broadcasting Introduces HD2PC(SM), the First-Ever High-Definition Direct to PC Delivery of Private Broadcast Television
7. JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes
8. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
9. Lilly Declares First-Quarter 2010 Dividend
10. FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology
11. CPG Implements First-Ever Agile PLM Release 9.3 at Avema Pharma Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3, 2015 Report ... New Drugs, Industry Changes and Emerging Opportunities What,s ... ovaries? Visiongain,s new study forecasts those pharmaceutical revenues. ... that industry. You also explore trends, results, treatments, ... report gives revenue predictions to 2025 at overall ...
(Date:9/3/2015)... About self-monitoring blood glucose device ... device. It consists of a glucose sensor and ... through radiowaves from the sensor to a receiver, ... self-monitoring blood glucose devices can improve self-management of ... diabetes treatment. Technavio,s analysts forecast the ...
(Date:9/3/2015)... Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... Stanley Global Healthcare Conference on Thursday, September 17, 2015 ... is scheduled to present at 11:45 a.m. ET.  The ... accessible in the "Investors" section of the company,s website ...
Breaking Medicine Technology:Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6Global Self-monitoring Blood Glucose Devices Market 2015-2019 2
... March 2, 2012  ZONARE Medical Systems, Inc., a leading ... results for the fourth quarter and fiscal year ended ... $70 million, resulting in 20% year-over-year sales growth. Sales ... company reported an operating profit for the quarter. More ...
...  Medical Science Liaisons (MSLs) have become a key link between ... leaders that drive marketplace success. And the role of MSLs ... in the coming years as the device industry turns to ... Given the expanding role of MSLs, it,s critical for ...
Cached Medicine Technology:ZONARE Reports Fourth Quarter and 2011 Results 2New Study Examines the Evolving Role of Medical Science Liaisons in the Medical Device Sector 2
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... he made the company the final destination of his six-month, 10,000 mile journey ... , During the trek—which he calls the “Connecting Las Americas” project—Max crossed ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Leadership® and Navigant Center for Healthcare Research and Policy Analysis has found physician ... , While 47 percent of respondents said their organizations conduct some ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Scholarship applications are open for spring 2016. Scholarships are awarded two times each ... For The Warriors® is a national nonprofit dedicated to restoring a sense of ...
(Date:9/3/2015)... ... September 03, 2015 , ... Today, ... Management Suite customers, as part of the LANDESK One Partner program. ... delivering the best mobile user experience in remote access and control:, ...
(Date:9/3/2015)... ... 03, 2015 , ... The first part of a two-part investigative news segment ... filter lawsuits filed against Bard.** These lawsuits, filed by persons and the family ... or failed, have recently been consolidated for pretrial proceedings as multidistrict litigation, MDL 2641 ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3
... results by a Swedish doctor involving more than 65, 000 ... sugar and the risk of developing cancer//. , Dr. Par ... data from 31,304 men and 33,293 women, led the research. ... and had glucose (blood sugar) measurements available. In total 2,478 cases ...
... higher body mass index (BMI) tend are less likely to ... , according to a report. ,An ischemic stroke ... the brain is blocked or reduced and sufficient amounts of ... weight are risk factors for stroke and may influence outcome ...
... School Dr. Aaron Lazare has decided to step down due ... cardiac arrhythmia. ,Dr. Lazare was responsible for the ... He has also set up the $ 100 million research ... of psychiatry and chair of the department after serving 14 ...
... TB burden, with about 40 per cent of the country's population// ... million people in India develop TB and 4,50,000 die from it, ... India than other infectious diseases, it has been reported. ... children under the age of 14 years. They are exposed to ...
... Scotland’s top golfer Colin Montgomerie says he will ‘do ... Roy Castle Lung Cancer Foundation//, to build a world-class specialty ... , The building will be named the Elizabeth ... from the disease in 1991.Montgomerie was very close to his ...
... by a specialist headache centre, it was observed that eight ... at work; 91 per cent blamed the ineffectiveness to headaches, ... published in the March issue of Cephalalgia. ,"Migraines ... when they are often at their most productive, so the ...
Cached Medicine News:Health News:Beware of High Sugar Levels Even If You are Not Diabetic 2Health News:Stroke Patients With High BMI Less Likely to Be Discharged After Hospitalization 2Health News:TB Incidence on Rise Among Children in Tamil Nadu, Maharashtra 2Health News:Golfer Plans ‘lasting Legacy’ for Moth 2Health News:Work Absence Due to Headaches Has a Substantial Socio-economic Effect 2
MBP's 200 ul large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
... an innovative, quick and easy automated ... 60% less space on your laboratory ... this amazingly easy-to-use, one-hand system, you ... whole range of Diamond Tips. All ...
... innovative, quick and easy automated refill ... less space on your laboratory bench ... amazingly easy-to-use, one-hand system, you only ... range of Diamond Tips. All sizes ...
10 L, Racked, 96 tips/rack Extended length pipette tips recommended for 5 and 10 L pipettes....
Medicine Products: